SurModics (SRDX) PT Lowered to $69 at Needham & Company
Needham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $69.00 (from $74.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
